Clinical Trials Directory

Trials / Unknown

UnknownNCT05316675

Impact of Isotretinoin in Different Doses on Quality of Life

Impact of Different Protocols of Systemic Isotretinoin in Acne Treatment on Quality of Life Among Egyptien Patients:Avalidity and Reliability Study

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
12 Years – 45 Years
Healthy volunteers
Accepted

Summary

The Cardiff Acne Disability Index is a short five-item questionnaire derived from the longer Acne Disability Index.It is designed for use in teenagers and young adults with acne. It is self explanatory and can be simply handed to the patient who is asked to complete it without the need for detailed explanation( .Abdelrazik etal., 2021). .

Detailed description

Lower doses of isotretinoin can be effective in terms of cost and decreasing systemic side effects. Therefore, other regimens may be used instead of daily conventional dose as alternate, pulse and low doses of oral isotretinoin in acne vulgaris( Agarwal et al., 2011). To study the impact of different protocols of systemic isotretinoin in acne treatment on quality of life among egyptian patients using Cardiff Acne Disability Index (CADI) and dermatology life quality index (DLQI)questionnaires. To assess validity and reliability of the translated Arabic version of CADI. To compare the clinical efficacy and tolerability of different protocols of systemic isotretinoin in acne treatment.

Conditions

Interventions

TypeNameDescription
DRUGIsotretinoinisotretinoin 13-cis-retinoic acid), derived from vitamin A

Timeline

Start date
2022-12-01
Primary completion
2024-10-01
Completion
2024-12-01
First posted
2022-04-07
Last updated
2022-04-07

Source: ClinicalTrials.gov record NCT05316675. Inclusion in this directory is not an endorsement.